|
5VOB
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21
Deposited 2017-05-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 10
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.2;293 K;10% (wt/vol) PEG400
10% isopropanol
2% (wt/vol) benzamidine
0.1M Tris pH 8.2
|
Resolution 3.02 Å
R-free 0.237
|
|
5VOC
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 8I21 - Low resolution dataset for initial phasing by SAD
Deposited 2017-05-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.2;293 K;10% (wt/vol) PEG400
10% isopropanol
2% (wt/vol) benzamidine
0.1M Tris pH 8.2
|
Resolution 3.99 Å
R-free 0.276
|
|
5VOD
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
Deposited 2017-05-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.2;293 K;10% (wt/vol) PEG methyl ether 500
0.1 M MES pH 6.2
0.00001 M phenol
|
Resolution 5.90 Å
R-free 0.299
|
|
5VOD
Crystal structure of HCMV Pentamer in complex with neutralizing antibody 9I6
Deposited 2017-05-02
|
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 14
PDB declaration: tetradecameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.2;293 K;10% (wt/vol) PEG methyl ether 500
0.1 M MES pH 6.2
0.00001 M phenol
|
Resolution 5.90 Å
R-free 0.299
|
|
7LBF
CryoEM structure of the HCMV Trimer gHgLgO in complex with human Platelet-derived growth factor receptor alpha and neutralizing fabs 13H11 and MSL-109
Deposited 2021-01-07
|
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5;The sample was gently cross-linked with 0.025% (v/v) EM-grade glutaraldehyde for 10 min at RT and quenched with 9 mM Tris pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 2.5 seconds before plunging
|
Resolution 2.80 Å
|
|
7LBG
CryoEM structure of the HCMV Trimer gHgLgO in complex with human Transforming growth factor beta receptor type 3 and neutralizing fabs 13H11 and MSL-109
Deposited 2021-01-07
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain A
1–715(715 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 17
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE;blot for 3.5 seconds before plunging
|
Resolution 2.60 Å
|